Literature DB >> 22132019

Selenium and stereotypies in a mental health setting.

Philip Ian Davies1, David Healy, Edward P Davies, Paul Green.   

Abstract

A 24-year-old man was referred with involuntary stereotypies of movement and thinking, of which he seemed unaware. On admission, comprehensive physical screening proved negative except for lowered selenium concentrations. Neuropsychological assessment revealed changes in performance on tests of attention, non-verbal reasoning and executive function consistent with his stereotypies. A review of his movements characterised them as possibly being consistent with non-paroxysmal kinesigenic dyskinesia. A low dose of sulpiride led to improvements in engagement and insight accompanied by modest reductions in movements.

Entities:  

Year:  2009        PMID: 22132019      PMCID: PMC3027968          DOI: 10.1136/bcr.07.2009.2053

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

Review 1.  Selenium deficiency and viral infection.

Authors:  Melinda A Beck; Orville A Levander; Jean Handy
Journal:  J Nutr       Date:  2003-05       Impact factor: 4.798

2.  The utility of SELENBP1 gene expression as a biomarker for major psychotic disorders: replication in schizophrenia and extension to bipolar disorder with psychosis.

Authors:  Tetsufumi Kanazawa; Gursharan Chana; Stephen J Glatt; Hideya Mizuno; Eliezer Masliah; Hiroshi Yoneda; Ming T Tsuang; Ian P Everall
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

3.  The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.

Authors:  C Randolph; M C Tierney; E Mohr; T N Chase
Journal:  J Clin Exp Neuropsychol       Date:  1998-06       Impact factor: 2.475

4.  Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues.

Authors:  Lutz Schomburg; Ulrich Schweizer; Bettina Holtmann; Leopold Flohé; Michael Sendtner; Josef Köhrle
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.